Home » Labopharm names Mark D'Souza as president
Labopharm names Mark D'Souza as president
March 15, 2011
Labopharm has named Mark D'Souza, the company's current CFO, as president and CEO of Labopharm and a member of the board of directors.
D'Souza replaces James Howard-Tripp as president and CEO. Howard-Tripp will also step down from the board.
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
Learn More Here